Compare $CLRB vs $SYBX | Chartloom

Compare

$CLRB vs $SYBX

Cellectar Biosciences Inc · Synlogic Inc

CLRB

Cellectar Biosciences Inc

SYBX

Synlogic Inc

Compare $CLRB vs $SYBX

Comparing Cellectar Biosciences Inc and Synlogic Inc

CLRBCellectar Biosciences Inc

SYBXSynlogic Inc

CLRBCellectar Biosciences Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-58.2%

52W performance

-69.7%

FCF yield

-168.2%

SYBXSynlogic Inc

Market cap

$13M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-6.0%

52W performance

-24.7%

FCF yield

-28.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLRB

SYBX

Detailed metrics comparison

CLRB

Cellectar Biosciences Inc

SYBX

Synlogic Inc

Market Cap

CLRB$12M

SYBX$13M

Enterprise Value

CLRB$-22M

SYBX$292K

Price

CLRB$1.45

SYBX$1.10

P/E Ratio

CLRBN/A

SYBXN/A

P/S Ratio

CLRB186.94x

SYBX4.20x

EV/Sales

CLRB-190.77x

SYBX0.09x

EV/EBITDA

CLRB0.00x

SYBX0.00x

P/B Ratio

CLRB0.56x

SYBX1.12x

P/FCF Ratio

CLRBN/A

SYBXN/A

EV/FCF

CLRB1.15x

SYBX-0.08x

PEG Ratio

CLRBN/A

SYBXN/A

Forward P/E (NTM)

CLRBN/A

SYBXN/A

Forward P/S (NTM)

CLRBN/A

SYBXN/A

Revenue (TTM)

CLRB$0

SYBX$0

Revenue Growth (YoY)

CLRBN/A

SYBXN/A

Forward Rev Growth

CLRB585.7%

SYBX0.0%

Gross Margin (TTM)

CLRB0.0%

SYBX0.0%

Operating Margin (TTM)

CLRB0.0%

SYBX0.0%

EBITDA Margin (TTM)

CLRB0.0%

SYBX0.0%

Net Margin (TTM)

CLRB0.0%

SYBX0.0%

FCF Margin (TTM)

CLRBN/A

SYBXN/A

Net Income (TTM)

CLRB$-22M

SYBX$-655K

FCF (TTM)

CLRB$-19M

SYBX$-4M

EPS (TTM)

CLRB-$1.83

SYBX-$0.05

ROE (TTM)

CLRB-16571.0%

SYBX-560.0%

ROA (TTM)

CLRB-11542.0%

SYBX-436.0%

ROIC (TTM)

CLRB-16571.0%

SYBX-560.0%

Cash

CLRB$34M

SYBX$13M

Debt

CLRB$0

SYBX$0

Net Cash/Debt

CLRB$34M

SYBX$13M

Current Ratio (TTM)

CLRB6.66x

SYBX9.19x

Quick Ratio (TTM)

CLRB6.49x

SYBX9.05x

Debt/Equity (TTM)

CLRB0.00x

SYBX0.00x

Debt/Assets (TTM)

CLRB0.0%

SYBX0.0%

Interest Coverage (TTM)

CLRBN/A

SYBXN/A

Net Debt/EBITDA (TTM)

CLRB0.00x

SYBX0.00x

Beta

CLRB0.58

SYBX0.87

52W Performance

CLRB-69.7%

SYBX-24.7%

YTD Performance

CLRB-58.2%

SYBX-6.0%

% from 52W High

CLRB-71.4%

SYBX-41.2%

% from 52W Low

CLRB8.2%

SYBX103.7%

Asset Turnover (TTM)

CLRB0.01x

SYBX0.05x

FCF Yield (TTM)

CLRB-168.2%

SYBX-28.5%

Earnings Yield (TTM)

CLRB-192.7%

SYBX-4.9%

Dividend Yield (TTM)

CLRBN/A

SYBXN/A

Rule of 40

CLRB0.0

SYBX0.0

EV/GP/RG

CLRBN/A

SYBXN/A

Ticker research

View CLRB research View SYBX research

Metric	CLRB Cellectar Biosciences Inc	SYBX Synlogic Inc
Market & Valuation
Market Cap	$12M	$13M
Enterprise Value	$-22M	$292K
Price	$1.45	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	186.94x	4.20x
EV/Sales	-190.77x	0.09x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.56x	1.12x
P/FCF Ratio	N/A	N/A
EV/FCF	1.15x	-0.08x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	585.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-22M	$-655K
FCF (TTM)	$-19M	$-4M
EPS (TTM)	-$1.83	-$0.05
ROE (TTM)	-16571.0%	-560.0%
ROA (TTM)	-11542.0%	-436.0%
ROIC (TTM)	-16571.0%	-560.0%
Financial Health
Cash	$34M	$13M
Debt	$0	$0
Net Cash/Debt	$34M	$13M
Current Ratio (TTM)	6.66x	9.19x
Quick Ratio (TTM)	6.49x	9.05x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	0.87
52W Performance	-69.7%	-24.7%
YTD Performance	-58.2%	-6.0%
% from 52W High	-71.4%	-41.2%
% from 52W Low	8.2%	103.7%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.05x
FCF Yield (TTM)	-168.2%	-28.5%
Earnings Yield (TTM)	-192.7%	-4.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLRB research	View SYBX research

Valuation

P/S Ratio

SYBX

4.20x

CLRB

186.94x

EV/FCF

SYBX

-0.08x

CLRB

1.15x

Growth & revenue

Forward Revenue Growth

CLRB

585.7%

SYBX

0.0%

Profitability & performance

Gross Margin

CLRB

0.0%

SYBX

0.0%

ROE

SYBX

-560.0%

CLRB

-16571.0%

FCF Yield %

SYBX

-28.5%

CLRB

-168.2%

52-Week Performance

SYBX

-24.7%

CLRB

-69.7%

Detailed metrics comparison

CLRB

Cellectar Biosciences Inc

SYBX

Synlogic Inc

Market Cap

CLRB$12M

SYBX$13M

Enterprise Value

CLRB$-22M

SYBX$292K

Price

CLRB$1.45

SYBX$1.10

P/E Ratio

CLRBN/A

SYBXN/A

P/S Ratio

CLRB186.94x

SYBX4.20x

EV/Sales

CLRB-190.77x

SYBX0.09x

EV/EBITDA

CLRB0.00x

SYBX0.00x

P/B Ratio

CLRB0.56x

SYBX1.12x

P/FCF Ratio

CLRBN/A

SYBXN/A

EV/FCF

CLRB1.15x

SYBX-0.08x

PEG Ratio

CLRBN/A

SYBXN/A

Forward P/E (NTM)

CLRBN/A

SYBXN/A

Forward P/S (NTM)

CLRBN/A

SYBXN/A

Revenue (TTM)

CLRB$0

SYBX$0

Revenue Growth (YoY)

CLRBN/A

SYBXN/A

Forward Rev Growth

CLRB585.7%

SYBX0.0%

Gross Margin (TTM)

CLRB0.0%

SYBX0.0%

Operating Margin (TTM)

CLRB0.0%

SYBX0.0%

EBITDA Margin (TTM)

CLRB0.0%

SYBX0.0%

Net Margin (TTM)

CLRB0.0%

SYBX0.0%

FCF Margin (TTM)

CLRBN/A

SYBXN/A

Net Income (TTM)

CLRB$-22M

SYBX$-655K

FCF (TTM)

CLRB$-19M

SYBX$-4M

EPS (TTM)

CLRB-$1.83

SYBX-$0.05

ROE (TTM)

CLRB-16571.0%

SYBX-560.0%

ROA (TTM)

CLRB-11542.0%

SYBX-436.0%

ROIC (TTM)

CLRB-16571.0%

SYBX-560.0%

Cash

CLRB$34M

SYBX$13M

Debt

CLRB$0

SYBX$0

Net Cash/Debt

CLRB$34M

SYBX$13M

Current Ratio (TTM)

CLRB6.66x

SYBX9.19x

Quick Ratio (TTM)

CLRB6.49x

SYBX9.05x

Debt/Equity (TTM)

CLRB0.00x

SYBX0.00x

Debt/Assets (TTM)

CLRB0.0%

SYBX0.0%

Interest Coverage (TTM)

CLRBN/A

SYBXN/A

Net Debt/EBITDA (TTM)

CLRB0.00x

SYBX0.00x

Beta

CLRB0.58

SYBX0.87

52W Performance

CLRB-69.7%

SYBX-24.7%

YTD Performance

CLRB-58.2%

SYBX-6.0%

% from 52W High

CLRB-71.4%

SYBX-41.2%

% from 52W Low

CLRB8.2%

SYBX103.7%

Asset Turnover (TTM)

CLRB0.01x

SYBX0.05x

FCF Yield (TTM)

CLRB-168.2%

SYBX-28.5%

Earnings Yield (TTM)

CLRB-192.7%

SYBX-4.9%

Dividend Yield (TTM)

CLRBN/A

SYBXN/A

Rule of 40

CLRB0.0

SYBX0.0

EV/GP/RG

CLRBN/A

SYBXN/A

Ticker research

View CLRB research View SYBX research

Metric	CLRB Cellectar Biosciences Inc	SYBX Synlogic Inc
Market & Valuation
Market Cap	$12M	$13M
Enterprise Value	$-22M	$292K
Price	$1.45	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	186.94x	4.20x
EV/Sales	-190.77x	0.09x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.56x	1.12x
P/FCF Ratio	N/A	N/A
EV/FCF	1.15x	-0.08x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	585.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-22M	$-655K
FCF (TTM)	$-19M	$-4M
EPS (TTM)	-$1.83	-$0.05
ROE (TTM)	-16571.0%	-560.0%
ROA (TTM)	-11542.0%	-436.0%
ROIC (TTM)	-16571.0%	-560.0%
Financial Health
Cash	$34M	$13M
Debt	$0	$0
Net Cash/Debt	$34M	$13M
Current Ratio (TTM)	6.66x	9.19x
Quick Ratio (TTM)	6.49x	9.05x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	0.87
52W Performance	-69.7%	-24.7%
YTD Performance	-58.2%	-6.0%
% from 52W High	-71.4%	-41.2%
% from 52W Low	8.2%	103.7%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.05x
FCF Yield (TTM)	-168.2%	-28.5%
Earnings Yield (TTM)	-192.7%	-4.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLRB research	View SYBX research